Cannabis Law Report

DECEMBER 14, 2021

(NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), announced today that it is the first company to formulate medical cannabis extract vaporizer pen products in a UK-based manufacturing premises, licensed and approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and Home Office.

Extraction 52

Extraction Patients Medicine Tincture 52

TheAnswerPage

JULY 17, 2022

Are CBD-rich extracts more effective at reducing seizures compared to purified CBD products? The analysis attempted to establish the safety and efficacy of the CBD products, and to determine if there is enough evidence to assume any difference in efficacy between CBD-rich extracts compared to purified CBD products.

Epilepsy 72

Epilepsy Extraction Treatment Data 72

TheAnswerPage

JULY 19, 2022

Have researchers found that patients who use cannabidiol (CBD)-rich extract therapy for the treatment of epilepsy require a lower dose of CBD medication as compared to those who use purified CBD therapy for the treatment of epilepsy? Pamplona F, da Silva L and Coan A. 12 September 2018. Sec.Neuropharmacology. See the Answer.

Epilepsy 52

Epilepsy Therapy Extraction Data 52

Cannabis Law Report

AUGUST 3, 2021

CSE: MXT) (OTCQB: MXTTF) is known for its award-winning extraction equipment, but recently, the company refocused its efforts on its proprietary health-related databases, machine learning analysis, and plans to engage in B2B licensing and mHealth. Data Bridge Market Research believes that psychedelics will grow at a 13.3%

Research and Development 105

Research and Development Data Conditions Therapy 105

Cannabis Law Report

MAY 12, 2022

Aurora Cannabis announced today that they will be launching a new product line for patients in the United Kingdom. Still, only a small number of patients actually get medical cannabis prescriptions and accessibility is still a hot button issue in the country.

Terpenes 52

Terpenes Extraction Advocacy Patients 52

Puff Puff Post

MARCH 2, 2020

tonnes approved, 50% are for Colombian domestic use and 50% are allowed for export purposes. · Export quotas allow for the manufacture of whole plant extract for international purposes to countries such as Peru, Uruguay, and Brazil, thereby accessing to a medical cannabis market of $1.4 . · Of the 9.3 Web Site: [link].

Extraction 40

Extraction THC Chronic Pain Cultivation 40

Veriheal

DECEMBER 23, 2022

Dr. Maxwell’s team also collected data contained in samples sourced from California. After a close analysis of the data, the team determined that an absence of consistent federal guidelines regarding marijuana contaminants ultimately increases the risk of consumers developing health issues. for extracts.

Research and Development 92

Research and Development Agriculture Data Extraction 92

TheAnswerPage

JULY 18, 2022

Do patients report more side effects from cannabidiol (CBD)-rich extract therapy or from purified CBD therapy? Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis Front. Pamplona F, da Silva L and Coan A. 12 September 2018.

Epilepsy 52

Epilepsy Therapy Extraction Treatment 52

The Joint Blog

MARCH 3, 2021

According to a new study published in the Journal of Cannabis Research, adjunctive marijuana use is associated with improvements in pain and other symptoms in patients with refractory fibromyalgia. herbal cannabis, oil extracts, etc.) in a cohort of 38 patients with treatment-resistant fibromyalgia.

Therapy 61

Therapy Hybrid Marijuana Research and Development 61

CannaMD

MAY 19, 2020

Working under a Health Canada research license, scientists involved with the study developed over 800 new cannabis lines and extracts, as well as a method of using them to regulate gene expression and molecular cascades that drive inflammation and other vital cellular processes. Our initial data suggest that some C.

Research and Development 131

Research and Development Sativa Marijuana Extraction 131

Project CBD

AUGUST 6, 2019

Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

The Joint Blog

MARCH 18, 2021

According to a new study titled Use of cannabinoids for the treatment of patients with post-traumatic stress disorder, the consumption of cannabinoids and cannabinoid products is safe and effective in the mitigation of symptoms of post-traumatic stress (PTS). Researchers examined studies that used both natural and synthetic THC and CBD.

Cannabinoids 26

Cannabinoids Patients Clinical Trials Research and Development 26

Cannabis Law Report

APRIL 29, 2022

LONDON, April 29, 2022 –( BUSINESS WIRE )–Curaleaf International (the “Company”) part of Curaleaf Holdings (CNSX:CURA), Europe’s largest vertically integrated cannabis company, is pleased to announce the successful license of the Company’s range of cannabis based medicines as extract, under the name Adven, in Malta.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Patients 52

Cannabis Law Report

DECEMBER 7, 2021

However, despite the increased use of MCs in children, there is limited data regarding their safety and efficacy in this population for those different indications 11. A systematic review published in 2017 aimed to identify available data about the therapeutic effect of cannabinoids treatment in children and adolescents.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JANUARY 4, 2022

By partnering with Gold Leaf in the early stages of their organization’s cultivation journey, we will play an instrumental role in helping their team fulfill their mission of supplying the medical market with the quality cannabis and consistent experiences patients and physicians have come to demand.”. BILLERICA, Mass.,

Extraction 52

Extraction Cultivation Programs Data 52

Project CBD

AUGUST 6, 2019

Just over 500 participants from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpublished data. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Leafwell

SEPTEMBER 9, 2017

Mara specializes in developing cannabis extracts, cannabis-infused olive oils, cannabis-infused coconut topicals and treatment protocols for seriously ill patients in California. A lot of Mara’s work is data-driven , which is definitely something that’s sorely needed in the cannabis industry at the moment.

Topical 73

Topical Data Extraction Oil 73

Cannabis Law Report

JUNE 29, 2021

is a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients. Our main product is the Ehave Dashboard which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insight using Blockchain technology. Ehave, Inc.

Clinical Trials 105

Clinical Trials Research and Development Data Patients 105

Cannabis Law Report

JUNE 30, 2021

Despite the high prevalence of these disorders, few patients are accurately screened and diagnosed. of patients with major depressive disorder, 92.7% of patients with bipolar disorder, 71% of patients with generalized anxiety disorder, and 97.8% of patients with social anxiety disorder. Building the Data Backend.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

The Joint Blog

DECEMBER 9, 2019

The twice-daily administration of plant-derived CBD-dominant extracts is associated with symptom improvement in adolescents with autism spectrum disorder (ASD), according to observational data published in the journal Frontiers in Neurology.

CBD 49

CBD Extraction Epilepsy Sativa 49

Cannabis Law Report

JANUARY 16, 2022

But Sativex — an oromucosal spray of a formulated cannabis extract with cannabidiol (CBD) as well as THC, the psychoactive chemical component in cannabis — was taken off the Malaysian market three years later as it was not commercially viable.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

CannaMD

AUGUST 19, 2020

While COVID-19 can be deadly, the World Health Organization (WHO) stresses that most patients experience mild cases and/or survive: Most people who get COVID-19 have mild or moderate symptoms and can recover thanks to supportive care. Our initial data suggest that some C. ” And their alternative strategy of choice?

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

Cannabis Law Report

SEPTEMBER 15, 2021

This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases. Of the 22 patients, 19 experienced adverse events after ingesting delta-8 THC-containing food products (e.g.,

THC 105

THC Pets Events Hemp 105

MMJ Recs

MARCH 16, 2024

Key factors influencing market size and revenue include patient demographics, regulatory frameworks, product offerings, and pricing strategies. Moreover, ensuring product quality and safety throughout the supply chain is paramount to maintain patient trust and regulatory compliance.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

The Cannigma

JUNE 23, 2022

The study also found that CBGA interacts with numerous other important receptors in the body like GPR55, TRPV1 channels, as well as GABA receptors, supporting further consideration and research for use in epileptic patients. He noted, “The data in the study isn’t really ready for translation to the clinic.” Pain and inflammation.

Cannabinoids 113

Cannabinoids Research and Development Clinical Trials Extraction 113

The Cannigma

JUNE 15, 2021

Some healthcare professionals are already encouraged by what is known, much of it anecdotal accounts from patients in their practices. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Indeed, the scientific literature regarding CBD and some forms of epilepsy is rich and full of data.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

APRIL 6, 2022

Furthermore, with Greenlight currently operating in five states, we believe our partnership will lead to further expansion into new geographies and the continued establishment of Agrify as the market leader in cannabis cultivation and extraction solutions.”. BILLERICA, Mass., About Greenlight. About Agrify (Nasdaq:AGFY).

Extraction 52

Extraction Cultivation Seed-To-Sale Events 52

Cannabis Law Report

JULY 12, 2021

Pure Extracts Inc. CSE: MSET) revealed additional preclinical data showing strong efficacy and improved safety in a head-to-head comparison with psilocybin. Meanwhile, investors continue to keep an eye on clinical results from many companies in the space. Market Performance. Weekly Performance: $133.19 (-1.61%). Powered by. CSE: PULL).

Treatment 66

Treatment Decriminalization Pharmaceutical Data 66

The Cannigma

MARCH 2, 2021

They argued that their findings suggest that doctors “outside of the VHA system who treat veteran patients may need to take the lead in conversations surrounding medical marijuana as a treatment option.”. As of January, 2021, PTSD was by far the most-listed qualifying condition in the state, with 57,661 out of 107,371 patients.

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. Types of Research. There’s another problem: science communication and literacy.

Research and Development 108

Research and Development Data THC Clinical Trials 108

The Joint Blog

JULY 17, 2020

According to a new study published in the journal Seminars in Pediatric Neurology, marijuana-based products are associated with improvements in the symptoms of autistic patients who have self-injurious behaviors and co-morbid epilepsy. The study is titled Autism Spectrum Disorder and medical cannabis: Review & clinical experience.

Epilepsy 47

Epilepsy Research and Development Marijuana Treatment 47

SpeedWeed

MARCH 26, 2021

This excessive inflammation, commonly known as a “cytokine storm,” is one of the leading causes of death in patients hospitalized with COVID. . This suggests that high-THC cannabis flower and full-spectrum pot extracts would not be able to combat the virus, although these compounds may help with other aspects of COVID recovery. .

CBD 52

CBD Clinical Trials Cannabinoids Patients 52

Cannabis Law Report

DECEMBER 11, 2021

“More than 40,000 patients have used cannabis to treat their respective illnesses. These clinics offer patients two types of medical cannabis: oil extracted from the seeds, and traditional cannabis remedies that use various parts of the plant including the leaves, roots or flowers. Most are cancer patients.

Oil 52

Oil Blood Pressure Concentrates Patients 52

Cannabis Law Report

JULY 6, 2021

Johnson, DSc, MD, MPhil, FRCPsych said, “I am pleased to join the Ehave Medical Advisory Board and look forward to working towards bringing psychedelic-assisted therapies to patients experiencing substance use issues. is a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Still, the FDA has not taken any concrete steps to regulate CBD, claiming that it needs more real-world data to move forward. “We Hemp Roundtable, the hemp industry’s national advocacy organization.

Safety 52

Safety Hemp Research and Development Data 52

SpeedWeed

MARCH 5, 2021

The investigators then performed an analysis of the data to quantify the relationships between lifetime cannabis use, 12-month cannabis use, and 12-month cannabis use frequency (at least monthly use and less than monthly use) and incidence of hypertension. Subjects in the study consumed cannabis by smoking or via oral cannabis oil extracts.

Blood Pressure 52

Blood Pressure Marijuana Data Therapy 52

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. . Most recently the FDA awarded MMJ International Holdings ?Orphan

DEA 66

DEA Clinical Trials THC Research and Development 66